Media coverage
9
Media coverage
Title Turning Point Therapeutics Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX-0022) at 2021 AACR-NCI-EORTC Conference and Provides Regulatory Updates Media name/outlet Morningstar.com Country/Territory United States Date 21/10/7 URL https://www.morningstar.com/news/globe-newswire/8369294/turning-point-therapeutics-presents-updated-preliminary-clinical-data-for-repotrectinib-and-elzovantinib-tpx-0022-at-2021-aacr-nci-eortc-conference-and-provides-regulatory-updates Persons Sunghoi Hong Title Turning Point Therapeutics Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX-0022) at 2021 AACR-NCI-EORTC Conference and Provides Regulatory Updates Media name/outlet TMC Net Country/Territory United States Date 21/10/7 URL www.tmcnet.com/usubmit/-turning-point-therapeutics-presents-updated-preliminary-clinical-data-/2021/10/07/9464711.htm Persons Sunghoi Hong Title Turning Point Therapeutics Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX-0022) at 2021 AACR-NCI-EORTC Conference and Provides Regulatory Updates Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 21/10/7 Persons Sunghoi Hong Title Turning Point Therapeutics Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX-0022) at 2021 AACR-NCI-EORTC Conference and Provides Regulatory Updates Media name/outlet ADVFN UK Country/Territory United Kingdom Date 21/10/7 URL https://uk.advfn.com/stock-market/NASDAQ/TPTX/share-news/Turning-Point-Therapeutics-Presents-Updated-Prelim/86238116 Persons Sunghoi Hong Title Turning Point Therapeutics Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX-0022) at 2021 AACR-NCI-EORTC Conference and Provides Regulatory Updates Media name/outlet Yahoo! Finance Country/Territory United States Date 21/10/7 URL https://finance.yahoo.com/news/turning-point-therapeutics-presents-updated-110000445.html Persons Sunghoi Hong Title Turning Point Therapeutics Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX-0022) at 2021 AACR-NCI-EORTC Conference and Provides Regulatory Updates Media name/outlet Stockwatch Country/Territory Canada Date 21/10/7 URL www.stockwatch.com/News/Item/U-z8369294-U!TPTX-20211007/U/TPTX Persons Sunghoi Hong Title Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX 0022) at 2021 AACR NCI EORTC Conference and Provides Regulatory Updates Media name/outlet Market News Publishing Country/Territory United States Date 21/10/7 Persons Sunghoi Hong Title Turning Point Therapeutics Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX-0022) at 2021 AACR-NCI-EORTC Conference and Provides Regulatory Updates Media name/outlet BizWire Express Country/Territory India Date 21/10/7 URL www.bizwireexpress.com/showstoryGNW.php?storyid=268414 Persons Sunghoi Hong Title Turning Point Therapeutics Presents Updated Preliminary Clinical Data for Repotrectinib and Elzovantinib (TPX-0022) at 2021 AACR-NCI-EORTC Conference and Provides Regulatory Updates Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 21/10/7 Persons Sunghoi Hong